Edgestream Partners, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Edgestream Partners, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$263,813
-87.1%
2,945
-90.6%
0.02%
-87.0%
Q2 2022$2,049,000
+61.3%
31,440
+56.5%
0.16%
+60.4%
Q1 2022$1,270,000
+7.4%
20,086
-9.9%
0.10%
+36.5%
Q4 2021$1,183,00022,2970.07%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders